New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

32

Boehringer Ingelheim partners with Lifebit

Lifebit Biotech Ltd. announced the beginning of a long-term partnership with Boehringer Ingelheim to utilize Natural Language Processing (NLP) and Artificial Intelligence (AI) for the detection and early reporting of global disease outbreaks using real-world data harvested from scientific publications and other open sources.

38

Byondis’ ADC Candidate Shows Prolonged PFS in HER-2+ Advanced Breast Cancer

Topline results from the Phase III TULIP study show an antibody-drug conjugate (ADC) from the Netherlands-based Byondis B.V. significantly prolonged progression-free survival (PFS) in patients with pretreated HER2-positive unresectable locally advanced or metastatic breast cancer (MBC).

40

Adhera, Bayer Subsidiaries Targeting Parkinson’s with Novel Approaches

Working through two subsidiaries, life sciences giant Bayer is taking multiple shots at Parkinson’s disease. In addition to Bayer’s efforts to tackle Parkinson’s, Adhera Therapeutics announced that the company will acquire a new class of drug aimed at the disease.